Illinois Compiled Statutes
720 ILCS 570/210 (2026)
(a) The controlled substances listed in this Section are included in Schedule IV
✓ current as of May 2026
Find cases:
SyfertCases citing this section
IL-ILGAilga.gov
JustiaChapter on Justia
CornellLII Search
CasesGoogle Scholar
(720 ILCS 570/210)
(from Ch. 56 1/2, par. 1210) Sec. 210. (a) The controlled substances listed in this Section are included in Schedule IV. (b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, as set forth below: (1) Not more than 1 milligram of difenoxin (DEA Drug | Code No. 9618) and not less than 25 micrograms of atropine sulfate per dosage unit. |
(2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, | 2-diphenyl-3-methyl-2-propionoxybutane). |
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for misuse associated with a depressant effect on the central nervous system: (1) Alprazolam; (2) Barbital; (2.1) Bromazepam; (2.2) Camazepam; (2.3) Carisoprodol; (3) Chloral Betaine; (4) Chloral Hydrate; (5) Chlordiazepoxide; (5.1) Clobazam; (6) Clonazepam; (7) Clorazepate; (7.1) Clotiazepam; (7.2) Cloxazolam; (7.3) Delorazepam; (8) Diazepam; (8.05) Dichloralphenazone; (8.1) Estazolam; (9) Ethchlorvynol; (10) Ethinamate; (10.1) Ethyl loflazepate; (10.2) Fludiazepam; (10.3) Flunitrazepam; (11) Flurazepam; (11.1) Fospropofol; (12) Halazepam; (12.1) Haloxazolam; (12.2) Ketazolam; (12.3) Loprazolam; (13) Lorazepam; (13.1) Lormetazepam; (14) Mebutamate; (14.1) Medazepam; (15) Meprobamate; (16) Methohexital; (17) Methylphenobarbital (Mephobarbital); (17.1) Midazolam; (17.2) Nimetazepam; (17.3) Nitrazepam; (17.4) Nordiazepam; (18) Oxazepam; (18.1) Oxazolam; (19) Paraldehyde; (20) Petrichloral; (21) Phenobarbital; (21.1) Pinazepam; (22) Prazepam; (22.1) Quazepam; (23) Temazepam; (23.1) Tetrazepam; (23.2) Tramadol; (24) Triazolam; (24.5) Zaleplon; (25) Zolpidem; (26) Zopiclone. (d) Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible: (1) Fenfluramine. (e) Unless specifically excepted or unless listed in another schedule any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (1.1) Diethylpropion; (1.2) Fencamfamin; (1.3) Fenproporex; (2) Mazindol; (2.1) Mefenorex; (3) Phentermine; (4) Pemoline (including organometallic complexes and | chelates thereof); |
(5) Pipradrol; (6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane); (7) Modafinil; (8) Sibutramine. (f) Other Substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substance, including its salts: (1) Butorphanol (including its optical isomers). (g) The Department may except by rule any compound, mixture, or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this Act if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for misuse of the substances which have a depressant effect on the central nervous system. (h) Except as otherwise provided in Section 216, any material, compound, mixture, or preparation that contains any quantity of the following substance having a stimulant effect on the central nervous system, including its salts, enantiomers (optical isomers) and salts of enantiomers (optical isomers): (1) Ephedrine, its salts, optical isomers and salts | of optical isomers. |
(Source: P.A. 103-881, eff. 1-1-25.) Notes of Decisions
Cited in 7
cases (1 in the last 5 years), 2015–2025 · leading case: Julio Najera-Rodriguez v. William P. Barr, 926 F.3d 343 (7th Cir. 2019).
Julio Najera-Rodriguez v. William P. Barr, 926 F.3d 343 (7th Cir. 2019). “The term "controlled substance" is defined in the Illinois act in 720 ILCS 570/102(f), which directs the reader in relevant part to "the Schedules of Article II of this Act," which in turn are found at 720 ILCS 570/204 (Schedule I), 720 ILCS 570/206 (Schedule II), 720 ILCS…”
Walker v. Dart, 2015 IL App (1st) 140087 (Ill. App. Ct. 2015). “Plaintiff's sample tested positive for oxazepam, which is a benzodiazephine and is a controlled substance under schedule IV of the Illinois Controlled Substances Act (720 ILCS 570/210(c)(18) (West 2010)). Following the positive result, an investigation was opened and a complaint…”
People v. Brantley, 2016 IL App (5th) 150177 (Ill. App. Ct. 2017). “He submitted to blood and urine testing, which revealed the presence of alprazolam, a controlled substance listed as a Schedule IV drug in the Illinois Controlled Substances Act (720 ILCS 570/210(c)(1) (West 2014)). A statutory summary suspension was scheduled to go into effect…”
Walker v. Dart, 2015 IL App (1st) 140087 (Ill. App. Ct. 2015). “Plaintiff’s sample tested positive for oxazepam, which is a benzodiazepine and is a controlled substance under schedule IV of the Illinois Controlled Substances Act (720 ILCS 570/210(c)(18) (West 2010)). Following the positive result, an investigation was opened and a complaint…”
Julio Najera-Rodriguez v. William P. Barr (7th Cir. 2019). “The term “controlled substance” is defined in the Illinois act in 720 ILCS 570/102(f), which directs the reader in relevant part to “the Schedules of Article II of this Act,” which in turn are found at 720 ILCS 570/204 (Schedule I), 720 ILCS 570/206 (Schedule II), 720 ILCS…”
Julio Najera-Rodriguez v. William P. Barr (7th Cir. 2019). “The term “controlled substance” is defined in the Illinois act in 720 ILCS 570/102(f), which directs the reader in relevant part to “the Schedules of Article II of this Act,” which in turn are found at 720 ILCS 570/204 (Schedule I), 720 ILCS 570/206 (Schedule II), 720 ILCS…”
People v. Ordner, 2025 IL App (5th) 230216-U (Ill. App. Ct. 2025). “¶8 The State requested that the trial court take judicial notice of Lorazepam’s status as a controlled substance and depressant, stating, “Lorazepam is a Schedule 4 controlled substance; and I cite 720 ILCS 570/210, Subsection 3, Sub-subsection (13).”
— 720 ILCS 570/210(c)(1) — 1 case
People v. Brantley, 2016 IL App (5th) 150177 (Ill. App. Ct. 2017). “He submitted to blood and urine testing, which revealed the presence of alprazolam, a controlled substance listed as a Schedule IV drug in the Illinois Controlled Substances Act (720 ILCS 570/210(c)(1) (West 2014)). A statutory summary suspension was scheduled to go into effect…”
— 720 ILCS 570/210(c)(18) — 2 cases
Walker v. Dart, 2015 IL App (1st) 140087 (Ill. App. Ct. 2015). “Plaintiff's sample tested positive for oxazepam, which is a benzodiazephine and is a controlled substance under schedule IV of the Illinois Controlled Substances Act (720 ILCS 570/210(c)(18) (West 2010)). Following the positive result, an investigation was opened and a complaint…”
Walker v. Dart, 2015 IL App (1st) 140087 (Ill. App. Ct. 2015). “Plaintiff’s sample tested positive for oxazepam, which is a benzodiazepine and is a controlled substance under schedule IV of the Illinois Controlled Substances Act (720 ILCS 570/210(c)(18) (West 2010)). Following the positive result, an investigation was opened and a complaint…”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.
|